Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1748-717X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer ; volume:6 ; number:1 ; day:30 ; month:6 ; year:2011 ; pages:1-7 ; date:12.2011
Radiation oncology ; 6, Heft 1 (30.6.2011), 1-7, 12.2011

Creator: Cheruvu, Praveena

Contributor: Metcalfe, Su K.
Metcalfe, Justin
Chen, Yuhchyau
Okunieff, Paul
Milano, Michael T.
SpringerLink (Online service)

DOI: 10.1186/1748-717X-6-80

URN: urn:nbn:de:1111-2016072615732

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cheruvu, Praveena
Metcalfe, Su K.
Metcalfe, Justin
Chen, Yuhchyau
Okunieff, Paul
Milano, Michael T.
SpringerLink (Online service)

Other Objects (12)

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Notch1 phenotype and clinical stage progression in non-small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer

Serum lipidome screening in patients with stage I non-small cell lung cancer

Related objects

Reset password